Will My Company’s Real Market Please Stand Up?

• Bio Strategy Partners

Because all companies – large and small – play to two principal audiences: 1) their customers and 2) their investors.

Chief among your investors’ principle concerns will be how savvy you are about identifying and targeting your specific market segment. We’ll deal with a number of key questions:

* Has management gone out into in the marketplace to
determine customer interest?

* Have the sales projections been made from the bottom
up?

* Does the company / product have an unfair competitive
advantage / proprietary technology?

* Does management have respect for the competition,
including an understanding of who brings what
competitive threats to the table?

* Where’s the competitive matrix? Is there a segmented
market target? Are the company’s pricing and COG
realistic / competitive?

* Who will pay, and is there existing reimbursement?

* Does everybody have a clear picture of what the playing
field looks like, and is everybody agreed on how to
attack the market?

* How your company’s management team packages the
science, the IP, your regulatory strategy and your exit
strategy together with your go-to-market sense and
sensibilities is critical to getting the funding you’ll
need.

Moderator:
H. Donlon Skerrett, President, PCCI (Pharmaceutical Consulting Consortium International)